CN115399390A - Salix purpurea and lotus leaf tea and preparation method thereof - Google Patents
Salix purpurea and lotus leaf tea and preparation method thereof Download PDFInfo
- Publication number
- CN115399390A CN115399390A CN202211052907.3A CN202211052907A CN115399390A CN 115399390 A CN115399390 A CN 115399390A CN 202211052907 A CN202211052907 A CN 202211052907A CN 115399390 A CN115399390 A CN 115399390A
- Authority
- CN
- China
- Prior art keywords
- tea
- cyclocarya paliurus
- lotus leaf
- lotus
- fresh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 121
- 240000002853 Nelumbo nucifera Species 0.000 title claims abstract description 87
- 235000006508 Nelumbo nucifera Nutrition 0.000 title claims abstract description 87
- 235000006510 Nelumbo pentapetala Nutrition 0.000 title claims abstract description 87
- 241001299682 Salix purpurea Species 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 235000013616 tea Nutrition 0.000 claims abstract description 85
- 241000233779 Cyclocarya paliurus Species 0.000 claims abstract description 54
- 239000002994 raw material Substances 0.000 claims abstract description 43
- 235000009569 green tea Nutrition 0.000 claims abstract description 35
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 25
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 25
- 241000124033 Salix Species 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000008187 granular material Substances 0.000 claims description 25
- 239000000463 material Substances 0.000 claims description 17
- 239000000835 fiber Substances 0.000 claims description 10
- 240000008042 Zea mays Species 0.000 claims description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 9
- 235000005822 corn Nutrition 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 241000233778 Cyclocarya Species 0.000 claims description 4
- 241000581835 Monodora junodii Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 20
- 239000008280 blood Substances 0.000 abstract description 20
- 150000002632 lipids Chemical class 0.000 abstract description 8
- 208000008589 Obesity Diseases 0.000 abstract description 7
- 235000020824 obesity Nutrition 0.000 abstract description 7
- 230000006378 damage Effects 0.000 abstract description 6
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 238000012545 processing Methods 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 241000220225 Malus Species 0.000 description 35
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 27
- 230000000694 effects Effects 0.000 description 19
- 235000012000 cholesterol Nutrition 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 11
- 230000036772 blood pressure Effects 0.000 description 10
- 108010023302 HDL Cholesterol Proteins 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 108010028554 LDL Cholesterol Proteins 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 102000016267 Leptin Human genes 0.000 description 4
- 108010092277 Leptin Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 4
- 229940039781 leptin Drugs 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 235000006468 Thea sinensis Nutrition 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000019606 astringent taste Nutrition 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000020333 oolong tea Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 206010065558 Aortic arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 201000001962 aortic atherosclerosis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000014590 basal diet Nutrition 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 231100000739 chronic poisoning Toxicity 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000028503 regulation of lipid metabolic process Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- -1 sponge Chemical compound 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 229940043263 traditional drug Drugs 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
The invention belongs to the technical field of tea processing, and particularly relates to green willow lotus leaf tea and a preparation method thereof. The salix purpurea and lotus leaf tea is prepared from the following raw materials in parts by weight: 1.2-1.5 g of cyclocarya paliurus, 1-1.3 g of lotus leaves, 0.4-0.5 g of Chinese waxgourd peels, 0.4-0.5 g of green tea and 0.4-0.5 g of apple grains, and the whole formula is naturally and evenly matched, has the advantages of slimming and lipid lowering, and no stomach injury through the synergistic effect among the raw materials, and has good application in the crowds with obesity and high blood fat.
Description
Technical Field
The invention relates to the technical field of tea processing, and particularly relates to salix chinensis and lotus leaf tea and a preparation method thereof.
Background
Along with the dramatic improvement of the living standard of people, the acceleration of the life rhythm and the change of the dietary structure, the global epidemic situation of obesity is severe, and the obesity becomes a worldwide disease which endangers the body health of people. Obesity increases the number of patients with fatty liver and hyperlipidemia, and the incidence of diseases such as hypertension, diabetes, cerebral apoplexy and the like is also increasing, so that obesity is becoming a 'universal source' of a plurality of chronic diseases. In the prior art, some medicines are used for intervention in the treatment of obesity, but the medicines have large side effects and are not suitable for long-term administration. Therefore, how to regulate the fat amount in human body by diet has important significance for clinical treatment, and the current edible intervention type common food replacing the traditional drug treatment has become a hot spot of research of food technologists. At present, most of health care tea sold in the market has weak pertinence, poor taste, harm to human body and poor effect. In view of the above, there is a need to research a tea prepared from folium Salicis Babylonicae and its preparation method to solve the above technical problems.
Disclosure of Invention
In order to solve the technical problems, the invention provides the Qingliu lotus leaf tea and the preparation method thereof, which aim to solve the problems in the prior art.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the invention provides salix purpurea and lotus leaf tea which is prepared from the following raw materials in parts by weight: 1.2 to 1.5g of cyclocarya paliurus, 1 to 1.3g of lotus leaves, 0.4 to 0.5g of Chinese waxgourd peel, 0.4 to 0.5g of green tea and 0.4 to 0.5g of apple granules.
Preferably, the composition is prepared from the following raw materials by weight: 1.5g of cyclocarya paliurus, 1g of lotus leaves, 0.5g of wax gourd peel, 0.5g of green tea and 0.5g of apple granules.
In addition, the raw materials used in the invention need to adopt: cyclocarya paliurus from Guizhou, lotus leaves from Shandong, chinese waxgourd peel from Anhui Bozhou, green tea from Fujian Nanan, and apple grains from Fujian Zhangzhou.
Cyclocarya paliurus has the effects of expanding blood vessels of heart vessels, improving blood circulation of heart, inhibiting blood sugar rise and lowering blood pressure. Because the cyclocarya paliurus leaves contain a plurality of important chemical components such as polysaccharide, triterpene, saponin, flavone and the like, and also contain a plurality of precious trace elements such as amino acid, vitamin, germanium, selenium, chromium, vanadium, zinc, iron, calcium and the like, the cyclocarya paliurus leaves can be processed into the cyclocarya paliurus substitute tea with the health-care functions of reducing blood sugar, blood fat, blood pressure, immunity improvement and the like by combining the ancient tea making process with the modern Chinese medicinal decoction piece processing process.
The cyclocarya paliurus produced in Guizhou is located at the high altitude of the mountains, the surrounding area has no heavy industry, the air is fresh and clean, and the quality of the cultivated cyclocarya paliurus is higher; the coumarins and flavonoids contained in cyclocarya paliurus have the effects of reducing blood pressure, resisting cancers, resisting bacteria, promoting urination, protecting vascular permeability, diminishing inflammation, resisting coagulation, expanding coronary arteries, improving blood circulation, protecting liver and gallbladder and reducing cholesterol, and if the raw materials in other areas are adopted and the content of substances in cyclocarya paliurus is insufficient, the effects of reducing blood pressure and blood fat and the like are greatly reduced or have no effect.
The lotus leaf and the flavonoid component in the lotus leaf have the functions of obviously reducing serum cholesterol (TC), reducing serum Triglyceride (TG), reducing weight and increasing the enzyme activity of serum HDL-C, HL and LPL of a rat with hyperlipidaemia. The lotus leaf extract can reduce the digestion ability of the body, reduce the absorption of lipid and carbohydrate, and strengthen the regulation of lipid metabolism and energy loss. The lotus leaf tea contains a large amount of fibers, and can promote the peristalsis of large intestine, help defecation and remove toxins. The lotus leaf tea is rich in tea leptin and improves metabolism, the tea leptin is a natural protein component of an appetite and energy balance regulation way, and no chemical component harmful to the body is added, so that side effects such as diarrhea, abdominal pain and the like are not caused. The absence of tea leptin can inhibit metabolism, reduce energy consumption efficiency, and cause obesity. The lotus leaf tea can supplement the tea leptin consumed by the human body in the intestinal tract, improve the metabolism of the human body and change the human body into the slimming body. The Weishan lake in Shandong is ecologically suitable for lotus to grow, the produced lotus leaves are green and full, the wild lotus leaves of the natural sweet Weishan lake are fragrant, green and environment-friendly, natural and pollution-free, the lotus leaves contain abundant trace elements required by human bodies, and the effects of reducing blood fat and blood pressure and the like are achieved by combining the lotus leaves with other raw materials more powerfully. The wild lotus leaves in the Weishan lake are green and environment-friendly, natural and pollution-free, contain more abundant trace elements required by a human body, and are more effectively matched with other raw materials to achieve the effects of reducing blood fat and blood pressure and the like.
White gourd peel: the exocarpium Benincase contains tartronic acid, can inhibit conversion of sugar into fat, has effect in inhibiting lipogenesis, and can be used for reducing weight. In addition, the Chinese waxgourd peel is cool in nature, has the effects of clearing summer-heat, can relieve scanty and brownish urine and summer-heat thirst due to excessive drinking in summer. The white gourd peel produced in Mazhou of Anhui has no sulfur fumigation and is not sour, and the quality and the process are more exquisite; compared with other sulfur-fumigated Chinese waxgourd peel materials, the quality of the Anhui Mao Chinese waxgourd peel is higher, the sulfur fumigation can make the raw materials sold better, but irreversible harm can be brought to a human body, the human body eats sulfur-fumigated Chinese medicinal materials, food can destroy the digestive tract and the respiratory system, the mucosa of the organs is damaged, variation is caused, organs such as liver and kidney functions are also damaged, sometimes, the sulfur for fumigating the medicinal materials is poorer in quality, the purity is not high, the Chinese waxgourd peel contains more heavy metals such as lead and mercury, and if the consumption is larger or the Chinese waxgourd peel materials are eaten for a long time, chronic poisoning can be caused.
Green tea (oolong tea): the pharmacological action of the green tea is highlighted in the aspects of fat decomposition, weight reduction, body building and the like. Oolong tea has effects of preventing and relieving blood lipid in aortic atherosclerosis. Drinking oolong tea can also reduce blood viscosity, prevent erythrocyte aggregation, improve blood hypercoagulable state, increase blood fluidity, improve microcirculation, and inhibit thrombosis.
Apple particles: after entering human body, apple pectin can combine with bile acid, absorb excessive cholesterol and triglyceride like sponge, and then is discharged out of body. The apple contains more potassium and less sodium, and can be used for lowering blood pressure. The apple contains flavonoid, and can reduce coronary heart disease and induce heart disease; apple contains abundant antioxidants, and can reduce the occurrence of cancer. Selecting fresh picked apples, granulating at low temperature, and freeze-drying to retain more than 90% of original flavor and nutrient substances of the apples.
The raw materials used in the invention and the gram weights of the raw materials are required to be strictly used according to the specified gram weight of the formula, and the total gram weight of 4g can be just 2000ml, so that the requirement of drinking water for adults (except pregnant women) every day is met. Cyclocarya paliurus and lotus leaves are main raw materials, and if the dosage of cyclocarya paliurus is insufficient, the effects of reducing blood pressure and blood fat and the like cannot be met, and if the dosage of cyclocarya paliurus is excessive, the cyclocarya paliurus can cause damage to adults with vigorous liver fire in the body, and the condition of the adults is aggravated. The lotus leaves are cold and cool in nature, and can damage yang qi of a human body when being taken excessively, and symptoms of spleen and stomach yang deficiency, abdominal pain and diarrhea can appear. The wax gourd peel can cause side effects such as diarrhea, abdominal pain and the like when being added excessively. Excessive addition of the green tea can inhibit calcium absorption and cause symptoms such as insomnia and the like. Apple granules are used for adjusting the taste and flavor of the product, and if the apple granules are added excessively, the risk of diarrhea is increased, the apple granules are fat, and the function burden of pancreatic islets is increased. The invention realizes the complementation of temperature and cool and natural balance by strictly studying the dosage of each component. Therefore, the amount of cyclocarya paliurus, lotus leaf, chinese waxgourd peel, green tea and apple grain can affect the efficacy. Therefore, the effects of slimming, body building, detumescence, diuresis, heat clearing, detoxifying, blood sugar stability maintaining and the like are achieved by reasonably matching the single raw materials, and the health-care tea is suitable for people with health-care requirements of slimming, three-high reducing, heat clearing, fire reducing and the like.
In a second aspect, the invention provides a preparation method of salix purpurea and lotus leaf tea, which comprises the following steps:
(1) Cleaning fresh cyclocarya paliurus, lotus leaves, exocarpium benincasae, green tea and apple granules, and then drying at high temperature until the water content of the cyclocarya paliurus, the lotus leaves, the exocarpium benincasae, the green tea and the apple granules is 2.0-2.5%;
(2) Uniformly mixing 1.2-1.5 g of cyclocarya paliurus, 1-1.3 g of lotus leaves, 0.4-0.5 g of exocarpium benincasae, 0.4-0.5 g of green tea and 0.4-0.5 g of apple granules dried in the step (1) to obtain a mixed raw material;
(3) Placing the mixed raw material in the step (2) into a scenting device paved with fresh scenting materials for low-temperature baking until the water content of the mixed raw material is 4.0-4.5%, so as to obtain scenting mixed tea;
(4) And (4) naturally cooling the scented mixed tea obtained in the step (3) at normal temperature, and packaging with a tea bag to obtain the Qingliu lotus leaf tea.
By adopting the method, the water content of the raw materials is 2.0-2.5% by drying the raw materials at high temperature, and the raw materials can completely emit water stuffiness and stale flavor. The mixed raw material is placed in a scenting device paved with fresh scenting materials for low-temperature baking, so that the water content of the mixed raw material is 4.0-4.5%; because the water content in the dry tea is low, the fresh scenting material in the scenting device has high water content, the water vapor carries the carrier of the fresh scenting material with fragrance, so that aromatic substances slowly enter the tea under the wrapping of the water vapor, the fragrance of the tea is gushed into leaves, meanwhile, the tea is changed slightly, and polyphenol substances causing bitter and astringent tastes start a series of complex conversion reactions, so that the taste of the tea is sweet, and the color of tea soup is changed from light green to clear yellow. Because the water content is increased from 2.0-2.5% to 4.0-4.5% in the scenting device, the water vapor can well wrap the fragrance into the mixed raw material, and the taste and the drug effect are enhanced. And the aroma and the drug effect of the mixed raw materials can be better preserved by low-temperature baking.
Preferably, the temperature of the high-temperature drying in the step (1) is 100-110 ℃.
Preferably, in the step (2), the cyclocarya paliurus is 1.5g, the lotus leaves are 1g, the wax gourd peel is 0.5g, the green tea is 0.5g, and the apple grains are 0.5g.
Preferably, the fresh scenting materials in the step (3) are fresh cyclocarya paliurus and fresh lotus leaves, the low-temperature baking temperature is 40-45 ℃, and the low-temperature baking time is 1-2 hours.
By adopting the method, the fresh cyclocarya paliurus and the fresh lotus leaves are used as the fresh scenting materials, so that the drug effect loss caused by high-temperature drying of the main raw materials can be compensated, and the taste can be enhanced.
Preferably, the weight ratio of the fresh cyclocarya paliurus to the fresh lotus leaves is 1.
Preferably, the tea bag in the step (4) is a corn fiber tea bag.
By adopting the method, the corn fiber can be decomposed into carbon dioxide and water under the action of microorganisms in soil and seawater, and the waste corn fiber does not pollute the earth environment and is an edible and degradable material. The corn fiber tea bag is absolutely safe and harmless to human bodies, belongs to edible grade, can resist high temperature of 130 ℃, and has no burden for tea making. Therefore, the corn fiber tea bag is green and environment-friendly.
In summary, compared with the prior art, the invention has the advantages that:
1. the salix purpurea and lotus leaf tea provided by the invention is prepared by reasonable raw material proportion and method, can be directly drunk after being brewed by hot water, and has sweet taste and no bitter taste and astringent taste. The health-care tea has the functions of slimming, promoting urination, clearing away heat and toxic materials, maintaining blood sugar, stabilizing and expanding blood vessels, improving cardiac blood circulation, lowering blood pressure, promoting gastrointestinal peristalsis, clearing summer-heat, promoting hair growth, clearing yang, promoting urination, lowering blood pressure, promoting urination, reducing swelling and preventing fat absorption by a body, is suitable for being drunk by obese patients, has the functions of slimming, promoting bowel defecation and smoothing stool.
2. The invention selects homologous plant raw materials, is matched with warm and cool materials, and mixes the cyclocarya paliurus, the lotus leaves, the wax gourd peels, the green tea and the apple granules, and the whole formula is naturally and evenly proportioned, thereby reducing weight and fat without hurting the stomach.
Detailed Description
The present invention is further described below.
Example 1
The salix purpurea and lotus leaf tea provided by the embodiment is prepared from the following raw materials in parts by weight: 1.5g of cyclocarya paliurus, 1g of lotus leaves, 0.5g of exocarpium benincasae, 0.5g of green tea and 0.5g of apple granules. The water content of cyclocarya paliurus, lotus leaf, exocarpium benincasae, green tea and apple grain is 4.0%, and the total amount is 4g.
The preparation method of the salix purpurea and lotus leaf tea comprises the following steps:
(1) Cleaning fresh cyclocarya paliurus, lotus leaves, exocarpium benincasae, green tea and apple granules, and drying at a high temperature of 100 ℃ to ensure that the water content of the cyclocarya paliurus, the lotus leaves, the exocarpium benincasae, the green tea and the apple granules is 2.0%;
(2) Uniformly mixing 1.5g of cyclocarya paliurus dried in the step (1), 1g of lotus leaves, 0.5g of wax gourd peels, 0.5g of green tea and 0.5g of apple granules to obtain a mixed raw material;
(3) Placing the mixed raw material in the step (2) in a scenting device paved with 2g of fresh cyclocarya paliurus and 2g of fresh lotus leaves, and baking at low temperature for 1h at 40 ℃ to enable the water content of the mixed raw material to be 4.0% so as to obtain scenting mixed tea;
(4) And (4) naturally cooling the scented mixed tea in the step (3) at normal temperature, and packaging the scented mixed tea in a corn fiber tea bag to obtain the salix cyclocarya leaves tea.
Example 2
The salix purpurea and lotus leaf tea provided by the embodiment is prepared from the following raw materials in parts by weight: 1.2g of cyclocarya paliurus, 1.3g of lotus leaves, 0.5g of wax gourd peel, 0.5g of green tea and 0.5g of apple granules. The water contents of cyclocarya paliurus, lotus leaf, exocarpium benincasae, green tea and apple grain are 4.0%, and the total amount is 4g.
The preparation method of the salix purpurea and lotus leaf tea comprises the following steps:
(1) Cleaning fresh cyclocarya paliurus, lotus leaves, exocarpium benincasae, green tea and apple grains, and drying at 110 deg.C to make the water content of cyclocarya paliurus, lotus leaves, exocarpium benincasae, green tea and apple grains 2.5%;
(2) Uniformly mixing 1.2g of cyclocarya paliurus dried in the step (1), 1.3g of lotus leaves, 0.5g of Chinese waxgourd peels, 0.5g of green tea and 0.5g of apple granules to obtain a mixed raw material;
(3) Placing the mixed raw material in the step (2) in a scenting device paved with 2g of fresh cyclocarya paliurus and 2g of fresh lotus leaves, and baking at a low temperature of 45 ℃ for 2 hours to enable the water content of the mixed raw material to be 4.5% to obtain scented mixed tea;
(4) And (4) naturally cooling the scented mixed tea in the step (3) at normal temperature, and packaging the scented mixed tea in a corn fiber tea bag to obtain the salix cyclocarya leaves tea.
Example 3
The salix purpurea and lotus leaf tea provided by the embodiment is prepared from the following raw materials in parts by weight: cyclocarya paliurus 1.5g, lotus leaf 1.3g, chinese waxgourd peel 0.4g, green tea 0.4g, and apple granules 0.4g. The water content of cyclocarya paliurus, lotus leaf, exocarpium benincasae, green tea and apple grain is 4.3%, and the total amount is 4g.
The preparation method of the salix purpurea and lotus leaf tea comprises the following steps:
(1) Cleaning fresh cyclocarya paliurus, lotus leaves, exocarpium benincasae, green tea and apple granules, and drying at a high temperature of 110 ℃ to ensure that the water content of the cyclocarya paliurus, the lotus leaves, the exocarpium benincasae, the green tea and the apple granules is 2.3%;
(2) Uniformly mixing 1.5g of cyclocarya paliurus dried in the step (1), 1.3g of lotus leaves, 0.4g of Chinese waxgourd peels, 0.4g of green tea and 0.4g of apple granules to obtain a mixed raw material;
(3) Placing the mixed raw material in the step (2) in a scenting device paved with 2g of fresh cyclocarya paliurus and 2g of fresh lotus leaves, and baking at a low temperature of 43 ℃ for 1.5 hours to enable the water content of the mixed raw material to be 4.4% to obtain scenting mixed tea;
(4) And (4) naturally cooling the scented mixed tea in the step (3) at normal temperature, and packaging the scented mixed tea in a corn fiber tea bag to obtain the salix cyclocarya leaves tea.
Example 4
The physical and chemical indexes and the nutritional ingredients of the green willow leaf tea prepared from 1.5g of the green willow prepared in the example 1, 1g of the green willow with the water content of 4.0 percent, 1g of the lotus leaf, 0.5g of the wax gourd peel, 0.5g of the green tea and 0.5g of the apple grain are analyzed, and the test results are shown in the table 1 and the table 2.
TABLE 1 nutrient component table of Qingliu lotus leaf tea
TABLE 2 physicochemical indices of Qingliu lotus leaf tea
As can be seen from tables 1 and 2, the willow lotus leaf tea disclosed by the invention not only has nutrient components, but also has no harm to human bodies; it has fresh fragrance, and no bitter and astringent taste.
Example 5 animal test efficacy validation
5.1 verification of weight-reducing efficacy
After 18 female KM mice were randomly fed with basal diet for 7 days, the animals were randomly divided into 3 groups by weight, which were a blank control group, a model group, and a folium Salicis Babylonicae group, each of which was 6.
The blank control group was fed with a normal diet having a fat content of 5%, and the model group and the test group were fed with a high fat diet of 50%. The green willow lotus leaf tea water obtained in the test group in the example 1 is perfused into the stomach at 8, 14 and 20 points every day (1 bag of the green willow lotus leaf tea is taken, the volume is fixed to 2000mL, and the tea bag is soaked for 1 hour), and the control group and the model group are replaced by equal amount of distilled water, and the stomach is perfused according to the weight of 1mL/10g of the mouse each time for 6 weeks continuously. During the period, all animals in each group had free access to water and food.
During the experiment, the mice in each group grew well and were active normally. The weight-losing and lipid-lowering effects of the mice were observed and analyzed by using a morphological method, and the weight growth rate of each group of mice is shown in a table 3 for the weight growth rate and the liver index change of the mice.
TABLE 3 mouse weight gain and liver index Change Table
Note: the initial and final body weights are averaged in the table
As can be seen from table 3, the folium islanding tea has the effect of losing weight, so that the weight growth rate and the liver index of the mice are both significantly lower than those of the high fat model group.
5.2 measurement of blood lipid level in mouse serum
Measuring total cholesterol, triglyceride, high density lipoprotein cholesterol and low density lipoprotein cholesterol in serum of the mouse to react with the blood lipid level, wherein the total cholesterol, triglyceride, high density lipoprotein cholesterol and low density lipoprotein cholesterol in the serum are important indexes for reacting the lipid metabolism of an organism, and the low density lipoprotein cholesterol is the origin of cardiovascular diseases; the high density lipoprotein cholesterol has the function of transporting cholesterol to liver for metabolism, and can reduce blood lipid by reducing total cholesterol, triglyceride and high density lipoprotein cholesterol and increasing low density lipoprotein cholesterol. The detection method comprises the following steps: a mouse serum sample fed for 6 weeks is placed in a 2mL sterile centrifuge tube, and four indexes of total cholesterol, triglyceride, high density lipoprotein cholesterol and low density lipoprotein cholesterol are measured by using a full-automatic biochemical analyzer. The effect of salix purpurea and lotus leaf tea on the blood lipid level of mice is shown in table 4.
Table 4 influence of salix purpurea and lotus leaf tea on blood lipid levels in mice results
Note: the data in the table include total cholesterol, triglyceride, HDL cholesterol, and LDL cholesterol increase, which are average values of the samples.
As can be seen from table 4, after the mice were fed for 6 weeks, the total cholesterol, triglyceride, and hdl cholesterol content of the mice in the model group were significantly higher than those of the blank control group, which were 2.16 times, 1.55 times, 1.81 times, and 2.33 times higher than those of the mice in the blank control group, respectively, indicating that the mice in the model group in the high-fat group had significant hyperlipidemia characteristics. For mice fed with the salix sinopurpurea and lotus leaf tea, the contents of total cholesterol, triglyceride and high-density lipoprotein cholesterol in serum are all obviously lower than those of a model high-fat group, but slightly higher than that of a blank control group. The results show that the salix purpurea and lotus leaf tea can reduce the contents of total cholesterol, triglyceride and low-density lipoprotein cholesterol and realize the regulation of the blood fat level.
In the description herein, references to the description of the term "one embodiment," "some embodiments," "an example," "a specific example," or "some examples," etc., mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
Although embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the present invention, and that variations, modifications, substitutions and alterations can be made in the above embodiments by those of ordinary skill in the art without departing from the principle and spirit of the present invention.
Claims (8)
1. The salix purpurea and lotus leaf tea is characterized by being prepared from the following raw materials in parts by weight: 1.2-1.5 g of cyclocarya paliurus, 1-1.3 g of lotus leaves, 0.4-0.5 g of Chinese waxgourd peels, 0.4-0.5 g of green tea and 0.4-0.5 g of apple granules.
2. The salix purpurea and lotus leaf tea as claimed in claim 1, is prepared from the following raw materials in parts by weight: 1.5g of cyclocarya paliurus, 1g of lotus leaves, 0.5g of wax gourd peel, 0.5g of green tea and 0.5g of apple granules.
3. A process for preparing the tea of Qingliuhe lotus leaf as claimed in claim 1 or 2 comprising the steps of:
(1) Cleaning fresh cyclocarya paliurus, lotus leaves, exocarpium benincasae, green tea and apple granules, and then drying at high temperature until the water content of the cyclocarya paliurus, the lotus leaves, the exocarpium benincasae, the green tea and the apple granules is 2.0-2.5%;
(2) Uniformly mixing 1.2-1.5 g of cyclocarya paliurus, 1-1.3 g of lotus leaves, 0.4-0.5 g of Chinese waxgourd peels, 0.4-0.5 g of green tea and 0.4-0.5 g of apple granules which are dried in the step (1) to obtain a mixed raw material;
(3) Placing the mixed raw material in the step (2) into a scenting device paved with fresh scenting materials for low-temperature baking until the water content of the mixed raw material is 4.0-4.5%, so as to obtain scented mixed tea;
(4) And (4) naturally cooling the scented mixed tea in the step (3) at normal temperature, and packaging with a tea bag to obtain the salix cyclocarya leaves tea.
4. The preparation method of the willow lotus leaf tea according to claim 3, wherein the high-temperature drying temperature in the step (1) is 100-110 ℃.
5. The preparation method of the cyclocarya paliurus and lotus leaf tea as claimed in claim 3, wherein in the step (2), the cyclocarya paliurus is 1.5g, the lotus leaf is 1g, the wax gourd peel is 0.5g, the green tea is 0.5g, and the apple granules are 0.5g.
6. The preparation method of the cyclocarya paliurus and lotus leaf tea as claimed in claim 3, wherein the fresh scenting materials in step (3) are fresh cyclocarya paliurus and fresh lotus leaves, the low-temperature baking temperature is 40-45 ℃, and the low-temperature baking time is 1-2 hours.
7. The preparation method of the cyclocarya paliurus and lotus leaf tea as claimed in claim 6, wherein the weight ratio of the fresh cyclocarya paliurus to the fresh lotus leaf is 1.
8. The method for preparing the willow lotus leaf tea according to claim 6, wherein the tea bag in the step (4) is a corn fiber tea bag.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211052907.3A CN115399390B (en) | 2022-08-31 | 2022-08-31 | Green willow lotus leaf tea and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211052907.3A CN115399390B (en) | 2022-08-31 | 2022-08-31 | Green willow lotus leaf tea and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115399390A true CN115399390A (en) | 2022-11-29 |
| CN115399390B CN115399390B (en) | 2024-03-15 |
Family
ID=84164486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211052907.3A Active CN115399390B (en) | 2022-08-31 | 2022-08-31 | Green willow lotus leaf tea and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115399390B (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100863817B1 (en) * | 2008-04-23 | 2008-10-16 | 시흥시 | Lotus leaf tea and its manufacturing method |
| CN102754710A (en) * | 2012-06-07 | 2012-10-31 | 王宇 | Blood sugar lowering tea |
| CN105104635A (en) * | 2015-07-23 | 2015-12-02 | 陆仁贵 | Composite cyclocarya paliurus tea, and preparation method thereof |
| CN106857991A (en) * | 2017-03-15 | 2017-06-20 | 广西凌云县盘古生态产业发展有限公司 | A kind of fat decreasing tea and preparation method thereof |
| CN108124996A (en) * | 2018-02-18 | 2018-06-08 | 王俊杰 | A kind of cyclocarya paliurus tea and its preparation process for improving damp-heat constitution |
| CN108902411A (en) * | 2018-08-13 | 2018-11-30 | 三江县心连心农业科技有限公司 | A kind of blue or green money willow compounded health tea and processing method |
| CN110150415A (en) * | 2019-06-20 | 2019-08-23 | 珠海林尚熙养生茶业有限公司 | A kind of three high tea-drinkings and preparation method thereof of tranquilizing the mind defaecation prevention |
| CN111134259A (en) * | 2020-02-18 | 2020-05-12 | 聂旭清 | Beverage composition and preparation method thereof |
| CN112471300A (en) * | 2020-11-24 | 2021-03-12 | 南京博医源健康信息咨询有限公司 | Formula and preparation method of medicinal and edible herbal tea capable of reducing blood pressure, blood fat and blood sugar |
| AU2020104313A4 (en) * | 2020-12-24 | 2021-03-18 | Nanjing Forestry University | Formula and processing technology of cyclocarya paliurus leaf weight-reducing hot compress medicine bag |
-
2022
- 2022-08-31 CN CN202211052907.3A patent/CN115399390B/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100863817B1 (en) * | 2008-04-23 | 2008-10-16 | 시흥시 | Lotus leaf tea and its manufacturing method |
| CN102754710A (en) * | 2012-06-07 | 2012-10-31 | 王宇 | Blood sugar lowering tea |
| CN105104635A (en) * | 2015-07-23 | 2015-12-02 | 陆仁贵 | Composite cyclocarya paliurus tea, and preparation method thereof |
| CN106857991A (en) * | 2017-03-15 | 2017-06-20 | 广西凌云县盘古生态产业发展有限公司 | A kind of fat decreasing tea and preparation method thereof |
| CN108124996A (en) * | 2018-02-18 | 2018-06-08 | 王俊杰 | A kind of cyclocarya paliurus tea and its preparation process for improving damp-heat constitution |
| CN108902411A (en) * | 2018-08-13 | 2018-11-30 | 三江县心连心农业科技有限公司 | A kind of blue or green money willow compounded health tea and processing method |
| CN110150415A (en) * | 2019-06-20 | 2019-08-23 | 珠海林尚熙养生茶业有限公司 | A kind of three high tea-drinkings and preparation method thereof of tranquilizing the mind defaecation prevention |
| CN111134259A (en) * | 2020-02-18 | 2020-05-12 | 聂旭清 | Beverage composition and preparation method thereof |
| CN112471300A (en) * | 2020-11-24 | 2021-03-12 | 南京博医源健康信息咨询有限公司 | Formula and preparation method of medicinal and edible herbal tea capable of reducing blood pressure, blood fat and blood sugar |
| AU2020104313A4 (en) * | 2020-12-24 | 2021-03-18 | Nanjing Forestry University | Formula and processing technology of cyclocarya paliurus leaf weight-reducing hot compress medicine bag |
Non-Patent Citations (2)
| Title |
|---|
| 邱陶瑞等主编: "《很老很老的老偏方 上班族小病小痛一扫光》", 华南理工大学出版社, pages: 195 * |
| 高章焕: "茉莉花茶窨制技术若干问题――兼答客问", 福建茶叶, no. 01, 20 April 1985 (1985-04-20), pages 195 - 4 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115399390B (en) | 2024-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103652361B (en) | Feed for postpartum sow in lactation period of 1-20 days and preparation method thereof | |
| KR101320374B1 (en) | Health Supplement Food, Feed, and Pharmaceutical Composition Comprising Chia Seed and Maca, and Manufacturing Method thereof | |
| CN110447902B (en) | Composition with weight-losing effect | |
| CN103416625A (en) | Barley piglet feed and preparation method thereof | |
| CN108404019A (en) | Compound chicory root adjusts the solid articles and preparation method thereof of purine metabolic disturbance | |
| CN106858215A (en) | A kind of passion fruit composite beverage | |
| CN106418501A (en) | Healthcare food with weight reducing function | |
| CN103168815A (en) | Gingko tartary buckwheat cookie and manufacturing method thereof | |
| KR20160032851A (en) | METHOD OF MANUFACTURING PILL COMPRISED OF Protaetia brevitarsis seulensis | |
| CN109222101A (en) | Composition and health food with effect of weight reducing | |
| CN1403017A (en) | Selenium-rich konjaku-green tea health food | |
| CN111387345A (en) | Compound polysaccharide composition and preparation method thereof | |
| CN107343935A (en) | A kind of pulvis for infant spleen-tonifying and preparation method thereof | |
| CN115399390B (en) | Green willow lotus leaf tea and preparation method thereof | |
| KR20090081062A (en) | A diabetes pharmaceutical composition and manufacturing process thereof | |
| CN103168814A (en) | Sea-buckthorn tartary buckwheat biscuit and manufacture method thereof | |
| KR101391647B1 (en) | Anti obesity composition | |
| KR20180056199A (en) | Manufacturing method of gum for diet containing Moringa Oleifera extract | |
| CN103181557A (en) | Nutritious food with slimming function and preparation method thereof | |
| CN106819223A (en) | A kind of health-care milk tea and preparation method thereof | |
| CN105815738A (en) | Product assisting in lowering blood glucose and preparation method thereof | |
| CN104491338B (en) | A kind of medicine-food dual-purpose composition to relax bowel and preparation method thereof | |
| CN106728478A (en) | A kind of granule of prevention malignant tumour | |
| CN107348479A (en) | A kind of preparation method of low energy compound probiotic draft ferment cream invigorant | |
| CN107319072A (en) | One kind relaxes bowel health preserving tea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |